Boerhaave Syndrome, also known as spontaneous esophageal rupture, is a rare condition with an estimated mortality of 20%-40%. Conventional surgical repair with the intention of primary repair remains the mainstay of treatment in esophageal rupture in Boerhaave syndrome. We present our experience with 2 cases that underwent laparoscopic transhiatal repair of esophageal rupture in Boerhaave Syndrome. Both cases presented with left chest and abdominal pain after vomiting, and were normotensive on admission. In both cases, the diagnosis of Boerrhaave Syndrome were made on Computer Tomographic (CT) scan. The patients underwent laparoscopic repair of the esophageal rupture successfully, and were subsequently discharged well on post-operative day 13 and 15 respectively. The laparoscopic transhiatal repair of esophageal rupture in Boerhaave Syndrome results in shorter length of hospital stay. The mean length of stay in the laparoscopic approach was 14 days (13 & 15days) in our series, as opposed to a mean of 20.5 days in patients who underwent open thoracotomy and washout with primary repair. There were no mortalities in either of the patients who underwent laparoscopic transhiatal repair in our series, however open thoracotomy and primary repair was associated with a mortality of 20%. The rarity of a ruptured esophagus makes comparison between the various treatment methods difficult. From our own experience and successful outcome in 2 such patients, we conclude that laparoscopic transhiatal repair of Boerhaave syndrome is a safe alternative to open repair in patients as the rupture often occurs in the lower end of the esophagus, provided there are no contraindications to laparoscopy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.